Group 1 - The core viewpoint emphasizes the need for a multidisciplinary collaborative treatment model for cardiovascular and cerebrovascular diseases, moving away from traditional single-discipline approaches [1] - The interconnection between heart and brain is highlighted, with studies showing that 28% to 31% of patients diagnosed with cerebrovascular diseases also have cardiovascular diseases, and over 50% of those diagnosed with cardiovascular diseases have cerebrovascular conditions [1] - The concept of "heart-brain co-treatment" is presented as a way to reduce treatment frequency and overall treatment time, benefiting patient recovery [1] Group 2 - Current challenges in heart-brain co-treatment include a lack of unified management protocols and treatment strategies, as well as barriers to interdisciplinary collaboration [2] - The "Healthy China Action - Implementation Plan for the Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases (2023-2030)" aims to establish a comprehensive prevention and early diagnosis system for these diseases nationwide by 2030 [2] - Efforts are being made to create platforms for heart-brain co-treatment, including the establishment of a clinical research database and AI-assisted treatment systems [2] - The rapid development of biotechnologies, such as gene and cell therapies, is reshaping disease treatment, necessitating deeper interdisciplinary integration [2] - The development in the field of heart-brain health requires breakthroughs across multiple dimensions, including precise control of cardiac rhythm and brain function, as well as embracing innovations from engineering, information technology, and artificial intelligence [2]

Core Viewpoint - Long-term migraines may be associated with cardiac structural abnormalities, particularly patent foramen ovale (PFO), which is a common heart condition that can lead to various neurological symptoms [1][2]. Group 1: Health Statistics and Conditions - As of 2023, over 330 million individuals in China suffer from cardiovascular diseases, with a rising prevalence [1]. - The incidence of migraines in patients with PFO is approximately five times higher than in the general population [1]. - PFO is present in about 20% to 34% of adults, often without noticeable symptoms [1]. Group 2: Medical Recommendations and Treatments - Patients experiencing unexplained headaches or dizziness, especially those with a history of stroke, are advised to undergo screening for PFO [2]. - If intervention is necessary, a minimally invasive procedure using a closure device is typically employed to close the PFO [2]. - Multidisciplinary collaboration in treatment is emphasized to enhance the management of complex conditions related to both cardiac and neurological health [2].